When consulting your primary care physician after the start of the school year, you expect to discuss colds or fatigue. In September 2026, the topics that come up in consultations are more varied: expanded vector risk, alerts regarding certain contraceptives, and an increase in pediatric emergency visits. Keeping up with the latest health information means first identifying signals that concretely change how to protect oneself or react to an unusual symptom.
West Nile Virus in France: Surveillance Extends Beyond the South
A resident of the Pays de la Loire who gets bitten by a mosquito at the end of summer does not think about West Nile. However, this is what the regional bulletins published by Santé publique France in September 2026 show: this area is now included in the enhanced surveillance perimeter, alongside the PACA region.
The vector risk is no longer limited to historically affected departments. For those living in rural or peri-urban areas in the West, the reflexes are the same as in the South: mosquito nets, skin repellents in the evening, and eliminating standing water around the home.
Sudden fever, headaches, muscle pain: the clinical picture of West Nile resembles a typical summer flu. By consulting this health information on Full Press, one realizes the importance of reporting any off-season flu-like syndrome to their doctor, especially when living in a newly affected region.
Desogestrel Contraception: What the ANSM Alert Changes
In September 2026, the ANSM began sending personalized letters to women using desogestrel-based contraception. The subject of the letter: a very low and rare risk of meningioma, now mentioned in the leaflets following a European recommendation.
The reflex of some patients might be to stop their pill immediately. The ANSM recommends not interrupting treatment without medical advice. The risk of an unwanted pregnancy remains statistically much more likely than that of meningioma.
How to React if Affected
Make an appointment with your doctor or midwife to assess the situation. There is no urgency to stop the pack. This letter is not a batch recall; it is a preventive information.
The decision is made during the consultation, not by reading a leaflet. Medical support allows for questions specific to each situation and, if necessary, to consider an appropriate contraceptive alternative.
Back to School and Pediatric Emergencies: The Signals of September 2026
An asthmatic child whose maintenance treatment was interrupted over the summer finds themselves unprotected at the very moment when triggers multiply. At the beginning of September 2026, the Oscour network recorded an increase in emergency visits among 2-14 year-olds, primarily for asthma attacks and suspected Covid-19 infections.
Several factors accumulate at the start of the school year:
- The return to group settings exposes children to respiratory viruses after several weeks in a restricted family circle, leading to a classic peak in consultations
- Fall allergens (dust mites, mold) add to indoor pollutants in classrooms, worsening crises in already sensitized children
- The circulation of Covid-19 remains lower than in previous years, but it persists and justifies maintaining barrier gestures among vulnerable children
Checking the asthma maintenance treatment before the start of the school year is part of the concrete actions that reduce emergency visits. It is a simple point to address during the follow-up visit with the doctor.
Biosimilar Medications: Why They Matter
When picking up your medication at the pharmacy and noticing that the name on the box has changed, the first reaction is often concern. Substitution with a biosimilar retains the same active ingredient, but the brand name may differ. Two concrete reflexes to keep in mind:
- Ask the pharmacist to clarify whether the medication dispensed is the same as usual or a newly referenced biosimilar
- Report any unusual side effects after a change, even minor ones, as pharmacovigilance relies partly on patient feedback
Keeping the box and label facilitates tracking in case of a reaction. Access to biosimilars is gradually expanding in France.
Physical Activity and Sedentariness: The Public Health France Program
Sitting for eight hours at a desk and then going for a thirty-minute run does not fully compensate for the effects of prolonged immobility. In September 2026, Public Health France communicated about its support for policies to combat sedentariness, with an evolving approach: moving from a generic message to targeted measures by age group and life context.
Sedentariness is not fought solely through sports. Reducing continuous sitting time, walking for short trips, standing up every hour: these micro-actions have a measurable effect on cardiovascular and metabolic risk, even without engaging in structured sports activity.
Public Health France is working to integrate this logic into professional and school environments, where periods of inactivity are most concentrated. For those who cannot find time to exercise, the goal is to regularly interrupt periods of immobility, not to aim for an ambitious training program.
The bulletins from Public Health France and communications from the ANSM remain the most reliable sources for following health alerts and regulatory updates in the coming months. Consulting them regularly allows one to distinguish real signals from rumors.
